Double-Dose Furmonertinib: Efficacy in EGFR Ex20ins NSCLC
In the realm of oncology, the landscape of targeted therapies is rapidly evolving. Recent research has illuminated the potential of ...
Tag: third-generation EGFR inhibitors
COMPEL Study Finds Adding Chemotherapy to Osimertinib After Progression Enhances Progression-Free Survival in EGFR-Mutated NSCLC
In a groundbreaking development in the treatment of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
High-Dose EGFR-TKIs Plus Pemetrexed Combat NSCLC
In the relentless battle against advanced non-small-cell lung cancer (NSCLC) harboring epidermal growth factor receptor mutations (EGFRm), a recent study ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!